![Jörn Drappa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jörn Drappa
Teknisk/Vetenskaplig/F&U Direktör på
ALUMIS INC.
Förmögenhet: 2 M $ per 2026-07-31
Profil
Jörn Drappa was the founder of Viela Bio, Inc., founded in 2018, where the title held was Chief Medical Officer, Head-Research & Development from 2018 to 2021.
The current job is Chief Medical Officer at Alumis, Inc. starting in 2022.
Former jobs include Associate Director-Medical at Amgen, Inc. from 2003 to 2006; Senior Medical Director at Genentech, Inc. from 2008 to 2011; Vice President-Clinical Development at MedImmune LLC from 2011 to 2018; Executive Vice President-Research & Development at Horizon Therapeutics Ltd. (Ireland) in 2021; Chief Medical Officer at Ventyx Biosciences, Inc. from 2021 to 2022; and Director at Alpine Immune Sciences, Inc. from 2022 to 2024.
Education includes a doctorate from Universität zu Köln conferred in 1991 and a doctorate from Weill Cornell Medicine.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ALUMIS INC. 0,05 % | 2026-08-03 | 56 892 ( 0,05 % ) | 2 M $ | 2026-07-31 |
Aktiva positioner av Jörn Drappa
| Företag | Position | Start |
|---|---|---|
| ALUMIS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-09-01 |
Tidigare kända positioner av Jörn Drappa
| Företag | Position | Slut |
|---|---|---|
| ALPINE IMMUNE SCIENCES, INC. | Direktör/Styrelseledamot | 2024-05-20 |
| VENTYX BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-05-05 |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Teknisk/Vetenskaplig/F&U Direktör | 2021-09-01 |
| VIELA BIO, INC. | Grundare | 2021-03-15 |
MedImmune LLC
 MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Teknisk/Vetenskaplig/F&U Direktör | 2018-02-01 |
Jörn Drappas utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
68
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
MedImmune LLC
MedImmune LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Horizon Therapeutics Ltd. (Ireland)
 Horizon Therapeutics Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Discovers, develops and manufactures pharmaceuticals for autoimmune & inflammatory diseases | Health Technology |
Universität zu Köln
 Universität zu Köln Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alpine Immune Sciences, Inc.
 Alpine Immune Sciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as an bio pharmaceutical company that develops immunotherapies for autoimmune and inflammatory diseases | Health Technology |
Viela Bio, Inc.
 Viela Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops treatments for inflammation and autoimmune diseases | Health Technology |
Weill Cornell Medicine
 Weill Cornell Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ventyx Biosciences, Inc.
 Ventyx Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapies for patients with autoimmune, inflammatory and neurodegenerative diseases | Health Technology |
Alumis, Inc.
 Alumis, Inc. Pharmaceuticals: MajorHealth Technology Engages in research and development of medicines for autoimmune disorders | Health Technology |
